Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
FNCH Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 27, 2024
Report Source: 2024 1st Quarter Report
Finch Therapeutics Group Inc. Stock Analysis FNCH
United States Health Care Nano Cap Report: Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. The company is headquartered in Boston, Massachusetts. The company went IPO on 2021-03-19. The company is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. The company has an intellectual property estate, including more than 113 issued U.S. and foreign patents with relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. Its assets include CP101, an orally administered microbiome candidate designed for the prevention of recurrent C. difficile infection (CDI), with positive clinical data from a Phase II randomized, placebo-controlled trial and a Phase II open-label trial, and pre-clinical assets that are designed to target ulcerative colitis, Crohn’s disease, and autism spectrum disorder. Additionally, it has also developed a biorepository of strains and samples.
Read More Finch Therapeutics Group Inc (FNCH) Chart
Key Statistics of Finch Therapeutics Group Inc (FNCH)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$8.50Volume
3127.00P/E Ratio (TTM)
-52 Week Range
Market Cap
21.28MAvg. Volume
4012.75Dividend Yield
-Financial Metrics & Statements of Finch Therapeutics Group Inc (FNCH)
FAQ's for Finch Therapeutics Group Inc (FNCH)
- According to Musaffa’s Shariah screening methodology, Finch Therapeutics Group Inc (FNCH) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Finch Therapeutics Group Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Finch Therapeutics Group Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Finch Therapeutics Group Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Finch Therapeutics Group Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Finch Therapeutics Group Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.